The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 997.00
Bid: 991.00
Ask: 993.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.202%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 997.00
KNOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

31 Jan 2024 16:09

RNS Number : 5824B
Kainos Group plc
31 January 2024

31 January 2024

Kainos Group plc

("Kainos" or the "Company")

Director / PDMR shareholdings

The Company has been notified of the following transactions in its ordinary Shares by Persons Discharging Managerial Responsibilities ("PDMRs") and their Persons Closely Associated ("PCA"):

· On 26 January 2024, Malachy Smith, Divisional Director, exercised share options granted in 2020 under the Company's Performance Share Plan. Mr Smith sold the ordinary shares on exercise at a price of £10.58.

· On 26 January that Nicola Smith, a PCA with Malachy Smith, sold 48,465 ordinary shares in the Company at a price of £10.50.

Following this notification, Mr Smith and his Person Closely Associated (PCA) have a reportable shareholding of 211,700 ordinary shares in the issued share capital of the Company, constituting 0.169% of the issued share capital of the Company.

Please note, the reportable shareholding of Mr Smith and his PCA was incorrectly declared in RNS No. 9003N, dated 27 September 2023. The correct reportable shareholding at that time was 260,165 ordinary shares, which is 0.207% of the total voting rights. This is corrected from 260,939 and 0.208% respectively in the original RNS.

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them.

(A19 Market Abuse Regulation)

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Malachy Smith

2.

Reason for the notification

a.

Position/status

Divisional Director

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

KNOS

b.

Nature of the transaction

Exercise of share options granted in 2020 under the Company's Performance Share Plan, and sale of shares.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

£10.58

11,535

d.

Aggregated information

· Aggregated volume

· Price

N/A

e.

Date of the transaction

26-01-24

f.

Place of the transaction

London Stock Exchange - XLON

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Nicola Smith

2.

Reason for the notification

a.

Position/status

PCA with Malachy Smith, Divisional Director

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

KNOS

b.

Nature of the transaction

Sale of Ordinary Shares

c.

Price(s) and volume(s)

Price(s)

Volume(s)

£10.50

48,465

d.

Aggregated information

· Aggregated volume

· Price

N/A

e.

Date of the transaction

26-01-24

f.

Place of the transaction

London Stock Exchange - XLON

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47

Ends

For further information, please contact:

Kainos via FTI Consulting LLP

Russell Sloan, Chief Executive Officer

Richard McCann, Chief Financial Officer

Investec Bank plc +44 20 7597 5970

Patrick Robb / Ben Griffiths

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Dwight Burden / Kwaku Aning

About Kainos

Kainos Group plc is a UK-headquartered IT provider with expertise across three divisions - Digital Services, Workday Services, and Workday Products.

Our Digital Services division develops and supports custom digital service platforms for public sector, commercial, and healthcare customers. Our solutions transform the delivery of these services, ensuring they are secure, accessible, and cost-effective, and provide better outcomes for users.

Our Workday Services division specialises in the deployment of Workday Inc.'s Finance, HR and Planning products to leading organisations across Europe and North America. We are one of Workday's most respected partners, experienced in complex deployment and trusted by our customers to launch, test, expand, and support their Workday systems.

Our Workday Products division develops products that complement Workday. Our Smart product suite, including Smart Test (for automated testing), Smart Audit (for compliance monitoring), and Smart Shield (for data masking), are used by more than 350 customers globally to safeguard their Workday systems.

Our people are central to our success. We employ more than 3,100 people in 23 countries across Europe, Asia and the Americas.

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us at www.kainos.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHQKDBKABKDADN
Date   Source Headline
28th Feb 201912:11 pmRNSTotal Voting Rights
25th Feb 20194:47 pmRNSHolding(s) in Company
12th Feb 20197:00 amRNSKainos announces site purchase for new Belfast HQ
6th Feb 20195:11 pmRNSAdmission of Shares to Trading
6th Feb 20193:59 pmRNSHolding(s) in Company
5th Feb 20194:01 pmRNSHolding(s) in Company
4th Feb 20194:11 pmRNSTotal Voting Rights
4th Feb 20197:00 amRNSTrading Update
6th Dec 20184:35 pmRNSPrice Monitoring Extension
5th Dec 20181:02 pmRNSDirector/PDMR Shareholding
3rd Dec 20181:38 pmRNSTotal Voting Rights
26th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSInterim Results
23rd Nov 20184:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20184:35 pmRNSPrice Monitoring Extension
12th Nov 20184:35 pmRNSPrice Monitoring Extension
2nd Nov 20185:02 pmRNSHolding(s) in Company
1st Nov 20183:57 pmRNSAdmission of Shares to Trading
1st Nov 20183:53 pmRNSBlock Admission
1st Nov 20183:49 pmRNSTotal Voting Rights
18th Oct 201812:07 pmRNSSecond Price Monitoring Extn
18th Oct 201812:02 pmRNSPrice Monitoring Extension
3rd Oct 20187:00 amRNSChange of Registered Office
1st Oct 20184:47 pmRNSTotal Voting Rights
20th Sep 20183:15 pmRNSAGM Statement
14th Sep 20184:06 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSTrading Update
23rd Aug 20183:40 pmRNSTotal Voting Rights
8th Aug 20182:21 pmRNSDirector/PDMR Shareholding
8th Aug 20182:20 pmRNSDirector/PDMR Shareholding
31st Jul 20183:00 pmRNSAnnual Report and Notice of AGM
24th Jul 20185:41 pmRNSTotal Voting Rights
24th Jul 20183:57 pmRNSDirector/PDMR Shareholding
13th Jul 20187:00 amRNSHolding(s) in Company
4th Jul 20184:51 pmRNSKainos Director/PDMR Shareholding
3rd Jul 201811:54 amRNSKainos Director/PDMR Shareholding
26th Jun 20187:00 amRNSCapital Markets Day
25th Jun 20181:17 pmRNSDirector's Declaration
29th May 20187:00 amRNSPreliminary Results
24th May 20183:08 pmRNSBoard Committee Membership
16th Apr 20187:25 amRNSTrading Update
23rd Mar 20181:06 pmRNSNotification Of Major Holding(s)
23rd Mar 20189:00 amRNSDirector Declaration
22nd Mar 20185:45 pmRNSHolding(s) in Company
23rd Jan 20188:00 amRNSKainos advances digital healthcare transformation
27th Nov 20177:00 amRNSInterim Results
24th Oct 20178:00 amRNSKainos expands its Workday operations in Europe
28th Sep 201711:32 amRNSResult of AGM
4th Sep 20177:00 amRNSTrading Update
17th Aug 20174:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.